Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nat Commun ; 11(1): 4608, 2020 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-32929085

RESUMEN

Actinobacteria produce antibacterial and antifungal specialized metabolites. Many insects harbour actinobacteria on their bodies or in their nests and use these metabolites for protection. However, some actinobacteria produce metabolites that are toxic to insects and the evolutionary relevance of this toxicity is unknown. Here we explore chemical interactions between streptomycetes and the fruit fly Drosophila melanogaster. We find that many streptomycetes produce specialized metabolites that have potent larvicidal effects against the fly; larvae that ingest spores of these species die. The mechanism of toxicity is specific to the bacterium's chemical arsenal: cosmomycin D producing bacteria induce a cell death-like response in the larval digestive tract; avermectin producing bacteria induce paralysis. Furthermore, low concentrations of volatile terpenes like 2-methylisoborneol that are produced by streptomycetes attract fruit flies such that they preferentially deposit their eggs on contaminated food sources. The resulting larvae are killed during growth and development. The phenomenon of volatile-mediated attraction and specialized metabolite toxicity suggests that some streptomycetes pose an evolutionary risk to insects in nature.


Asunto(s)
Bacterias/metabolismo , Drosophila melanogaster/citología , Drosophila melanogaster/microbiología , Actinobacteria/fisiología , Animales , Antraciclinas/farmacología , Antibacterianos/química , Antibacterianos/farmacología , Canfanos/toxicidad , Muerte Celular/efectos de los fármacos , Drosophila melanogaster/efectos de los fármacos , Larva/efectos de los fármacos , Larva/microbiología , Metaboloma , Esporas Bacterianas/metabolismo , Esporas Bacterianas/fisiología , Streptomyces/fisiología , Análisis de Supervivencia , Compuestos Orgánicos Volátiles/farmacología
2.
J Ind Microbiol Biotechnol ; 43(2-3): 233-48, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26433385

RESUMEN

Environmental microbes produce biologically active small molecules that have been mined extensively as antibiotics and a smaller number of drugs that act on eukaryotic cells. It is known that there are additional bioactives to be discovered from this source. While the discovery of new antibiotics is challenged by the frequent discovery of known compounds, we contend that the eukaryote-active compounds may be less saturated. Indeed, despite there being far fewer eukaryotic-active natural products these molecules interact with a far richer diversity of molecular and cellular targets.


Asunto(s)
Bacterias/química , Productos Biológicos/farmacología , Eucariontes/efectos de los fármacos , Eucariontes/metabolismo , Animales , Antibacterianos/aislamiento & purificación , Antibacterianos/farmacología , Productos Biológicos/química , Productos Biológicos/aislamiento & purificación , Eucariontes/química , Eucariontes/citología , Humanos , Terapia Molecular Dirigida
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...